EUCTR2014-001022-14-DE进行中（未招募）1 期
An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 1,650
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Males and females at least 18 years old at screening
- •2. Females must be post-menopausal for more than 2 years or surgically sterile or practicing acceptable forms of birth control
- •3. Males must be surgically sterile or agree to practice acceptable forms of birth control
- •4. Chronic HCV infection prior to study enrollment.
- •5. Screening laboratory result indicating HCV genotype 1 infection.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 1470
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 180
排除标准
- •1. Use of contraindicated medication within 2 weeks of dosing
- •2. Abnormal laboratory tests
- •3. Current or past clinical evidence of Child-Pugh B or C classification or history of liver decompensation
- •4. Confirmed presence of hepatocellular carcinoma
- •5. History of solid organ transplant
研究者
相似试验
进行中（未招募）
不适用
An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectioChronic Hepatitis C InfectionMedDRA version: 17.0Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2014-001022-14-ITAbbVie Deutschland GmbH & Co. KG1,650
已完成
3 期
An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (TOPAZ-I).chronische hepatitis C-virusinfectieChronic Hepatitis C Virus Infectioninfectious disease affecting primarily the liver10047438NL-OMON55830AbbVie Ltd.21
进行中（未招募）
不适用
An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectioChronic Hepatitis C InfectionMedDRA version: 17.0Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2014-001022-14-GBAbbVie Deutschland GmbH & Co. KG1,650
进行中（未招募）
1 期
An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectioChronic Hepatitis C InfectionMedDRA version: 17.1Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2014-001022-14-SEAbbVie Deutschland GmbH & Co. KG1,650
进行中（未招募）
1 期
An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectioEUCTR2014-001022-14-DKAbbVie Deutschland GmbH & Co. KG1,650